Mirum Pharmaceuticals: Funding, Investors & Team (Sep 2026)
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.
Mirum Pharmaceuticals has raised $761M across 3 funding rounds on record, the most recent an undisclosed round of $600M announced in May 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Mirum Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: May 2026.
Mirum Pharmaceuticals Funding Rounds
Mirum Pharmaceuticals raised $92.0M in a Post-IPO Equity announced in Aug 2022.
3.3 years later, an undisclosed round of $68.5M was announced in Dec 2025.
5 months later, an undisclosed round of $600M was announced in May 2026.
Mirum Pharmaceuticals Founders and Leadership Team
Contact details for the Mirum Pharmaceuticals team: 2 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Mirum Pharmaceuticals Funding Compared to Other Biotechnology Startups
Mirum Pharmaceuticals' latest round of $600M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Mirum Pharmaceuticals in Biotechnology and San Diego
Companies Similar to Mirum Pharmaceuticals
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Mirum Pharmaceuticals Funding FAQs
What does Mirum Pharmaceuticals do?
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.
How much funding has Mirum Pharmaceuticals raised?
Mirum Pharmaceuticals has raised $761M across 3 rounds on record. The most recent is an undisclosed round of $600M announced in May 2026.
When did Mirum Pharmaceuticals last raise funding?
Mirum Pharmaceuticals' most recent funding round on record is an undisclosed round of $600M, announced in May 2026.
Who founded Mirum Pharmaceuticals?
FundedIQ lists Alejandro Dorenbaum (Founder), Chris Peetz (Founder) at Mirum Pharmaceuticals.
Where is Mirum Pharmaceuticals headquartered?
Mirum Pharmaceuticals is based in San Diego, California, United States.
How many employees does Mirum Pharmaceuticals have?
Mirum Pharmaceuticals is in the 101-250 employee band.
How does Mirum Pharmaceuticals' funding compare to other Biotechnology startups?
Mirum Pharmaceuticals' latest round of $600M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Mirum Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Mirum Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.